Kian Guan Lim, Angel Investor
Mr. Lim is a serial entrepreneur who is a member of the FUSION GENOMICS board and has helped a number of biotechnology and health-related companies grow to maturity. His areas of expertise include leading teams, developing products, creating distribution networks, and establishing key partnerships. He is actively involved in setting the strategy of the company and has been responsible for introducing the bulk of the angel investors to us.
T. Michael Underhill PhD
Dr. Underhill is a Professor in the Department of Cellular and Physiological Sciences at the University of British Columbia. He has also served as the Scientific Director at the Centre for Drug Research and Development, a not-for-profit independent organization promoting and facilitating commercialization of academia-based discoveries.
Poul Sorensen MD, PhD, Co-Founder, Medical Advisor
Dr. Sorensen uses a combination of genetic and biochemical approaches to identify and discover proteins that are specifically altered in childhood cancers and adult breast tumours. His initial discoveries have been translated by FUSION GENOMICS into new diagnostic tests for specific tumours, and have advanced our understanding of how the involved proteins transmit signals that cause cells to become cancerous. Dr. Sorensen is also the Chair of the Translational Research Committee of the Children’s Oncology Group (COG), the largest pediatric oncology clinical trials network in the world.
Richard M. Anthony PhD
Dr. Anthony is a Molecular Biologist who specializes in molecular diagnostics. He has extensive experience in development of molecular tests for bacterial drug resistance, bacterial and fungal typing, and microarray-based diagnostics. His work as Research Coordinator for the tuberculosis research group in KIT Biomedical Research is directed towards improving tuberculosis diagnostics.